Cytotoxic Activity of Vancomycin-Resistant Enterococci Isolated from Hospitalised Patients
Pathogens · 2024
DOI: 10.3390/pathogens13100827 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pathogens, 2024. Verfasst von Ewa Szczuka und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Faculty of Biology, Institute of Experimental Biology, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego 6,…. Hauptthemen laut MEDLINE: Gram-Positive Bacterial Infections, Anti-Bacterial Agents, Vancomycin-Resistant Enterococci, Enterococcus faecium. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Vancomycin-resistant enterococci (VRE) are considered one of the main nosocomial pathogens due to their increasing antibiotic resistance and ability to cause life-threatening infections in humans. This study included VRE isolates obtained from various specimens including urine, blood, faeces, wounds, sputum, and oral cavity wash. Of the 37 strains, 30 (81.1%) and 7 (18.9%) were identified by MALDI TOF as Enterococcus faecium and Enterococcus faecalis, respectively. The clinical vancomycin-resistant enterococci exhibited multi-drug resistance (MDR). Apart from vancomycin, the enterococci exhibited resistance to penicillins (89.1 to 100%), fluoroquinolones (100%), rifampicin (86.5%), tetracycline (27%), aminoglycosides (56.8 to 86.5%), quinupristin–dalfopristin (35.1%), and chloramphenicol (10.8%). Moreover, resistance to linezolid and tigecycline emerged among the tested vancomycin-resistant enterococci. The analysis of aminoglycoside modifying enzyme (AME) genes showed the presence of bifunctional aac(6′)-Ie-aph(2″)-Ia genes contributed to high-level aminoglycoside resistance (HLAR) in the E. faecalis and E. faecium isolates. The other AME gene, i.e., aph(3′)-IIIa, was also found in the VRE isolates. All strains carried the vanA gene. Enterococci from colonised gastrointestinal tracts (1/2.7%) and from infection (6/16.2%) showed cytotoxic activity against the human epithelial cell line HEp-2.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Microbiology, Faculty of Biology, Institute of Experimental Biology, Adam Mickiewicz University in Poznań, Uniwersytetu Poznańskiego 6, 61-614 Poznań, Poland.
- Microbiology Laboratory, University Clinical Hospital in Poznań, ul. Przybyszewskiego 49, 60-355 Poznań, Poland.
ORCID-Profile: Ewa Szczuka, Maria Wesołowska
Zitieren
APA
Szczuka, E., Rolnicka, D., & Wesołowska, M. (2024). Cytotoxic Activity of Vancomycin-Resistant Enterococci Isolated from Hospitalised Patients. Pathogens. https://doi.org/10.3390/pathogens13100827
Vancouver
Szczuka E, Rolnicka D, Wesołowska M. Cytotoxic Activity of Vancomycin-Resistant Enterococci Isolated from Hospitalised Patients. Pathogens. 2024. doi:10.3390/pathogens13100827
BibTeX
@article{Szczuka2024,
author = {Szczuka, Ewa and Rolnicka, Dominika and Wesołowska, Maria},
title = {Cytotoxic Activity of Vancomycin-Resistant Enterococci Isolated from Hospitalised Patients},
journal = {Pathogens},
year = {2024},
doi = {10.3390/pathogens13100827}
}
EUVIMED